sellModerate cluster of 2
Eric Schoen sold $238k of FLNA
Chief Financial Officer at CASSAVA SCIENCES INC. 61,800 shares at an average of $3.86, traded Nov 29, 2024, filed Dec 3, 2024.
Warning score
48Value
$238k
61,800 shares
Holdings after
11,500
-3090% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +22RoleCFO
- +13Trade size$238k at market
- +20Share of holdings soldSold 100% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001437749-24-036546, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 29, 2024 | MOption exercise Common Stock | +50,000 | $1.18 | $59k | 71,300 | Dec 3, 2024 |
| Nov 29, 2024 | SOpen-market sale Common Stockindirect: By limited liability corporation | -2,000 | $3.82 | $7,640 | 0 | Dec 3, 2024 |
| Nov 29, 2024 | SOpen-market sale Common Stock | -59,800 | $3.86 | $231k | 11,500 | Dec 3, 2024 |
| Nov 29, 2024 | MOption exercise Stock Option (Right to Buy)derivative | -50,000 | $0.00 | $0 | 0 | Dec 3, 2024 |
Related signals
Other insiders at CASSAVA SCIENCES INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 58Moderate | FLNAbuy CASSAVA SCIENCES INC | Richard Barry President & CEO | $278k 306,813 shares | +30% | |
| 45Moderate | FLNAbuy CASSAVA SCIENCES INC | Richard Barry President & CEO | $78k 93,091 shares | +10% | |
| 39Weak | CASSAVA SCIENCES INC | Robert Eugene Anderson Jr director | $25k 8,600 shares | - | |
| 65Notable | CASSAVA SCIENCES INC | Richard Barry President & CEO | $414k 150,000 shares | +19% | |
| 61Notable | CASSAVA SCIENCES INC | Richard Barry President & CEO | $202k 73,385 shares | +10% | |
| 50Moderate | CASSAVA SCIENCES INC | Robert Christopher Cook Chief Operating & Legal Office | $40k 13,725 shares | - | |
| 46Moderate | CASSAVA SCIENCES INC | Richard Barry President & CEO | $16k 7,172 shares | +1% | |
| 69Notable | CASSAVA SCIENCES INC | Richard Barry President & CEO | $535k 237,941 shares | +51% | |
| 43Moderate | CASSAVA SCIENCES INC | James William Kupiec Chief Medical Officer | $15k 4,000 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.